From: Becker's Supply Chain Report <>
Subject: Top Boston hospitals in 'urgent need' of platelet donations | In $1B deal, ICU Medical to buy Pfizer's infusion business | Mylan pushes back release date of generic EpiPen | Geisinger refunds patients $400k for 'uncompensated care'
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube

Oct. 7, 2016

1. Congress pushes for more answers on Mylan's EpiPen profits  Full story
Dana-Farber, Brigham and Women's in 'urgent need' of platelet donations  Full story
3. Clinicians should take stock of patients, not shelves: 3 thoughts on supply chain's role in patient care  Full story
4. Find out how you can stop overlooking freight spend and see an immediate impact to your bottom line in this upcoming webinar  Learn more 
5. ICU Medical to buy Pfizer's infusion business for $1B 
6. Is Congress to blame for high drug prices?
 7. Upcoming webinar: The 7 Pillars of Successful Bundling: Orthopedics and Beyond 
8. 5 drugs awaiting FDA review in October 
9. Mylan pushes back release date of generic EpiPen  Full story
10. J&J warns patients about cybersecurity vulnerabilities in insulin pump 
11. Coastal hospitals prepare for Hurricane Matthew  Full story 
12. Geisinger refunds patients $400k for 'uncompassionate care'
Full story

13. US manufacturing index rose to 51.5 in September  Full story

Call for submissions - "Supply chain tip of the week": If you would like to contribute a tip, insight or best practice related to improving the hospital supply chain, please email Mackenzie Bean at

Contact Us

Editorial Contact: 
Molly Gamble 
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO

Becker's Hospital Review
A Becker's Healthcare Publication
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by in collaboration with
Constant Contact